Compare ORI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORI | BAX |
|---|---|---|
| Founded | 1923 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 12.1B |
| IPO Year | 1994 | 1994 |
| Metric | ORI | BAX |
|---|---|---|
| Price | $41.08 | $21.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 9 |
| Target Price | ★ $43.50 | $21.00 |
| AVG Volume (30 Days) | 1.6M | ★ 6.0M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 9.47% | 0.24% |
| EPS Growth | ★ 14.81 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | $9,136,300,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $7.07 | $1.96 |
| Revenue Next Year | $6.86 | $2.22 |
| P/E Ratio | $31.52 | ★ N/A |
| Revenue Growth | ★ 10.99 | 5.72 |
| 52 Week Low | $35.60 | $15.73 |
| 52 Week High | $46.76 | $29.35 |
| Indicator | ORI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 49.64 |
| Support Level | $40.49 | $21.16 |
| Resistance Level | $43.36 | $22.41 |
| Average True Range (ATR) | 0.74 | 0.69 |
| MACD | -0.13 | -0.20 |
| Stochastic Oscillator | 23.39 | 14.90 |
Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.